These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

739 related items for PubMed ID: 26861926

  • 1. Metabolic Impact of Nonalcoholic Steatohepatitis in Obese Patients With Type 2 Diabetes.
    Lomonaco R, Bril F, Portillo-Sanchez P, Ortiz-Lopez C, Orsak B, Biernacki D, Lo M, Suman A, Weber MH, Cusi K.
    Diabetes Care; 2016 Apr; 39(4):632-8. PubMed ID: 26861926
    [Abstract] [Full Text] [Related]

  • 2. Plasma Fibroblast Growth Factor 21 Is Associated With Severity of Nonalcoholic Steatohepatitis in Patients With Obesity and Type 2 Diabetes.
    Barb D, Bril F, Kalavalapalli S, Cusi K.
    J Clin Endocrinol Metab; 2019 Aug 01; 104(8):3327-3336. PubMed ID: 30848827
    [Abstract] [Full Text] [Related]

  • 3. High Prevalence of Nonalcoholic Fatty Liver Disease in Patients With Type 2 Diabetes Mellitus and Normal Plasma Aminotransferase Levels.
    Portillo-Sanchez P, Bril F, Maximos M, Lomonaco R, Biernacki D, Orsak B, Subbarayan S, Webb A, Hecht J, Cusi K.
    J Clin Endocrinol Metab; 2015 Jun 01; 100(6):2231-8. PubMed ID: 25885947
    [Abstract] [Full Text] [Related]

  • 4. Clinical and Histologic Characterization of Nonalcoholic Steatohepatitis in African American Patients.
    Bril F, Portillo-Sanchez P, Liu IC, Kalavalapalli S, Dayton K, Cusi K.
    Diabetes Care; 2018 Jan 01; 41(1):187-192. PubMed ID: 29133343
    [Abstract] [Full Text] [Related]

  • 5. Hepatic Steatosis and Insulin Resistance, But Not Steatohepatitis, Promote Atherogenic Dyslipidemia in NAFLD.
    Bril F, Sninsky JJ, Baca AM, Superko HR, Portillo Sanchez P, Biernacki D, Maximos M, Lomonaco R, Orsak B, Suman A, Weber MH, McPhaul MJ, Cusi K.
    J Clin Endocrinol Metab; 2016 Feb 01; 101(2):644-52. PubMed ID: 26672634
    [Abstract] [Full Text] [Related]

  • 6. IMPACT OF TYPE 2 DIABETES ON NONALCOHOLIC STEATOHEPATITIS AND ADVANCED FIBROSIS IN PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASE.
    Bian H, Zhu X, Xia M, Yan H, Chang X, Hu X, Pan B, Guo W, Li X, Gao X.
    Endocr Pract; 2020 Apr 01; 26(4):444-453. PubMed ID: 31968197
    [Abstract] [Full Text] [Related]

  • 7. High Prevalence of Nonalcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Mellitus and Normal Plasma Aminotransferase Levels.
    Portillo Sanchez P, Bril F, Maximos M, Lomonaco R, Biernacki D, Orsak B, Subbarayan S, Webb A, Hecht J, Cusi K.
    J Clin Endocrinol Metab; 2014 Oct 10; 100(5):. PubMed ID: 25303488
    [Abstract] [Full Text] [Related]

  • 8. Prevalence of prediabetes and diabetes and metabolic profile of patients with nonalcoholic fatty liver disease (NAFLD).
    Ortiz-Lopez C, Lomonaco R, Orsak B, Finch J, Chang Z, Kochunov VG, Hardies J, Cusi K.
    Diabetes Care; 2012 Apr 10; 35(4):873-8. PubMed ID: 22374640
    [Abstract] [Full Text] [Related]

  • 9. Relationship between disease severity, hyperinsulinemia, and impaired insulin clearance in patients with nonalcoholic steatohepatitis.
    Bril F, Lomonaco R, Orsak B, Ortiz-Lopez C, Webb A, Tio F, Hecht J, Cusi K.
    Hepatology; 2014 Jun 10; 59(6):2178-87. PubMed ID: 24777953
    [Abstract] [Full Text] [Related]

  • 10. The role of liver fat and insulin resistance as determinants of plasma aminotransferase elevation in nonalcoholic fatty liver disease.
    Maximos M, Bril F, Portillo Sanchez P, Lomonaco R, Orsak B, Biernacki D, Suman A, Weber M, Cusi K.
    Hepatology; 2015 Jan 10; 61(1):153-60. PubMed ID: 25145475
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Influence of adiposity, insulin resistance, and intrahepatic triglyceride content on insulin kinetics.
    Smith GI, Polidori DC, Yoshino M, Kearney ML, Patterson BW, Mittendorfer B, Klein S.
    J Clin Invest; 2020 Jun 01; 130(6):3305-3314. PubMed ID: 32191646
    [Abstract] [Full Text] [Related]

  • 14. Metabolic and histological implications of intrahepatic triglyceride content in nonalcoholic fatty liver disease.
    Bril F, Barb D, Portillo-Sanchez P, Biernacki D, Lomonaco R, Suman A, Weber MH, Budd JT, Lupi ME, Cusi K.
    Hepatology; 2017 Apr 01; 65(4):1132-1144. PubMed ID: 27981615
    [Abstract] [Full Text] [Related]

  • 15. Nonalcoholic fatty liver disease: a feature of the metabolic syndrome.
    Marchesini G, Brizi M, Bianchi G, Tomassetti S, Bugianesi E, Lenzi M, McCullough AJ, Natale S, Forlani G, Melchionda N.
    Diabetes; 2001 Aug 01; 50(8):1844-50. PubMed ID: 11473047
    [Abstract] [Full Text] [Related]

  • 16. Association of serum retinoic acid with hepatic steatosis and liver injury in nonalcoholic fatty liver disease.
    Liu Y, Chen H, Wang J, Zhou W, Sun R, Xia M.
    Am J Clin Nutr; 2015 Jul 01; 102(1):130-7. PubMed ID: 25948673
    [Abstract] [Full Text] [Related]

  • 17. [Analysis of metabolic risk factors for developing nonalcoholic fatty liver in patients with type 2 diabetes mellitus].
    Guo M, Xi G, Yang N, Yao H.
    Zhonghua Gan Zang Bing Za Zhi; 2014 Aug 01; 22(8):631-5. PubMed ID: 25243967
    [Abstract] [Full Text] [Related]

  • 18. Elevated plasma copeptin levels identify the presence and severity of non-alcoholic fatty liver disease in obesity.
    Barchetta I, Enhörning S, Cimini FA, Capoccia D, Chiappetta C, Di Cristofano C, Silecchia G, Leonetti F, Melander O, Cavallo MG.
    BMC Med; 2019 Apr 30; 17(1):85. PubMed ID: 31035998
    [Abstract] [Full Text] [Related]

  • 19. Role of ethnicity in overweight and obese patients with nonalcoholic steatohepatitis.
    Lomonaco R, Ortiz-Lopez C, Orsak B, Finch J, Webb A, Bril F, Louden C, Tio F, Cusi K.
    Hepatology; 2011 Sep 02; 54(3):837-45. PubMed ID: 21674556
    [Abstract] [Full Text] [Related]

  • 20. Retinol-binding protein 4 is associated with impaired glucose tolerance but not with whole body or hepatic insulin resistance in Mexican Americans.
    Chavez AO, Coletta DK, Kamath S, Cromack DT, Monroy A, Folli F, DeFronzo RA, Tripathy D.
    Am J Physiol Endocrinol Metab; 2009 Apr 02; 296(4):E758-64. PubMed ID: 19190263
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 37.